NEW! – Calmer Canine™, an Anxiety Management System for Dogs
The NPAID® (Non-Pharmaceutical Anti-Inflammatory Device) seal on the Assisi Loop confirms the device has been scientifically proven to alleviate pain and inflammation in animals without the undesirable effects caused by extended use of pharmaceuticals.
What is an NPAID?
Quite simply, NPAID refers to the class of medical devices that employ some form of electromagnetic therapy in the treatment of inflammatory conditions in humans and animals. The term has been coined to emphasize this technology as a non-pharmaceutical option to non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed class of drugs for treating pain and inflammation in humans and animals.
NSAIDs, steroids, and opiates are three classes of pharmaceutical treatments that are part of the standard of care for certain inflammatory and traumatic conditions. NPAIDs that employ specifically targeted electromagnetic waveforms constitute a fourth class of treatment for treating inflammation and managing pain in humans and animals.
NPAIDs may be used to treat:
- Orthopedic Injuries
- Degenerative Disorders
- Neurological Issues
- Post-Surgical Pain & Swelling
- Inflammatory Conditions
- Wounds
When the complications of standard treatments narrow, consider an NPAID.
How does an NPAID work?
The mechanism of action for any type of NPAID depends on the specific configuration and intensity of the electromagnetic waveform within the part of the spectrum that is employed by the device.
Pulsed electromagnetic field (PEMF) technology is an increasingly recognized member of this class of devices. PEMF devices typically employ electric microcurrents to generate a low-intensity, sub-thermal, pulsed electromagnetic field.
The configuration and intensity of the resultant electromagnetic waveform can be targeted to enhance a specific biological and chemical reaction in human and animal tissues. For example, the FDA-cleared PEMF waveform long used in bone growth stimulators promotes calcium formation in recalcitrant fractures. Another patented PEMF waveform cleared by the FDA for reducing postoperative pain and edema has been targeted to enhance the production of nitric oxide in damaged tissues and to stimulate vasodilation for increased blood flow.
Sign up for our newsletter
